In your Trust please supply the number of patients currently being treated with biologics for the following conditions, split by named biologic;
-
Rheumatoid Arthritis
-
Ankylosing Spondylitis [if split by individual Arthropathy is not possible, please state total for Spondylarthropathies]
-
Psoriatic Arthritis
-
Psoriasis
-
Crohn's disease
Total Patients and where possible split by Biologic;
-
Abatacept [Orencia]
-
Adalimumab [Humira]
-
Anakinra [Kineret]
-
Certolizumab [Cimzia]
-
Etanercept [Enbrel]
-
Infliximab [Remicade]
-
Rituximab [Mabthera]
-
Tocilizumab [Ro Actemra]
-
Ustekinumab [Stelara]
-
Others
Patients on biologics